Immunostaining studies show EphB4 expression is localized to the tumor core, while ephrin-B2 is more widely distributed, suggesting that EphB4-ephrin-B2 interactions may help retain tumor cells centrally and limit peripheral invasion (Kawahara et al., 2019). This evidence concerns the gene EFNB2 and neoplasm.